scholarly journals Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease

2008 ◽  
Vol Volume 3 ◽  
pp. 637-658 ◽  
Author(s):  
Sabah Hussain ◽  
Kim Cheol ◽  
M Mofarrahi
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Skeletal Muscle ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Muscle Dysfunction ◽  
Obstructive Pulmonary Disease ◽  
Skeletal Muscle Dysfunction

scholarly journals AMP-Activated Protein Kinase (AMPK) at the Crossroads Between CO2 Retention and Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease (COPD)

2020 ◽  
Vol 21 (3) ◽  
pp. 955 ◽  
Author(s):  
Joseph Balnis ◽  
Tanner C. Korponay ◽  
Ariel Jaitovich
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Skeletal Muscle ◽  
Pulmonary Disease ◽  
Future Research ◽  
Chronic Obstructive ◽  
Muscle Dysfunction ◽  
Ribosomal Biogenesis ◽  
Obstructive Pulmonary Disease ◽  
Skeletal Muscle Dysfunction ◽  
Amp Activated Protein Kinase

Skeletal muscle dysfunction is a major comorbidity in chronic obstructive pulmonary disease (COPD) and other pulmonary conditions. Chronic CO2 retention, or hypercapnia, also occur in some of these patients. Both muscle dysfunction and hypercapnia associate with higher mortality in these populations. Over the last years, we have established a mechanistic link between hypercapnia and skeletal muscle dysfunction, which is regulated by AMPK and causes depressed anabolism via reduced ribosomal biogenesis and accelerated catabolism via proteasomal degradation. In this review, we discuss the main findings linking AMPK with hypercapnic pulmonary disease both in the lungs and skeletal muscles, and also outline potential avenues for future research in the area based on knowledge gaps and opportunities to expand mechanistic research with translational implications.

Sign in / Sign up

Export Citation Format

Share Document